Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_assertion type Assertion NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_head.
- NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_assertion description "[Phylogenetic analysis of the S-polymerase gene sequences showed that 66.7% (36/54) of the patients were infected with genotype D (D1, D2, D3), 25.9% (14/54) with genotype A (A1, A2), 5.6% (3/54) with subgenotype C2, and 2% (1/54) with genotype E. A comparison of virological characteristics showed significant differences between genotypes A, C and D. The comparison between HBeAg status and the G1896A stop codon mutation in patients with genotype D revealed a relationship between HBV G1896A precore mutants and genotype D and hepatitis B e antigen (HBeAg) seroconversion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_provenance.
- NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_assertion evidence source_evidence_literature NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_provenance.
- NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_assertion SIO_000772 25626648 NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_provenance.
- NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_assertion wasDerivedFrom befree-2016 NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_provenance.
- NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_assertion wasGeneratedBy ECO_0000203 NP1258885.RABmOlbUDGN5KCmb2F94_eE0gCIW6MavbXUukG4vebAYc130_provenance.